...
首页> 外文期刊>Orphanet journal of rare diseases >Treatment of thoracolumbar kyphosis in patients with mucopolysaccharidosis type I: results of an international consensus procedure
【24h】

Treatment of thoracolumbar kyphosis in patients with mucopolysaccharidosis type I: results of an international consensus procedure

机译:I型粘多糖贮积症患者胸腰段后凸畸形的治疗:国际共识程序的结果

获取原文
           

摘要

Abstract BackgroundIn all patients with mucopolysaccharidosis type I (MPS I), skeletal disease (dysostosis multiplex) is a prominent, debilitating, condition related complication that may impact strongly on activities of daily living. Unfortunately, it is not alleviated by treatment with hematopoietic cell transplantation (HCT) or enzyme replacement therapy (ERT). Although early kyphosis is one of the key features of dysostosis multiplex, there is no international consensus on the optimal management. Therefore, an international consensus procedure was organized with the aim to develop the first clinical practice guideline for the management of thoracolumbar kyphosis in MPS I patients.MethodsA literature review was conducted to identify all available information about kyphosis and related surgery in MPS I patients. Subsequently, a modified Delphi procedure was used to develop consensus statements. The expert panel included 10 spinal orthopedic surgeons, 6 pediatricians and 3 physiotherapists, all experienced in MPS I. The procedure consisted of 2 written rounds, a face-to-face meeting and a final written round. The first 2 rounds contained case histories, general questions and draft statements. During the face-to-face meeting consensus statements were developed. In the final round, the panel had the opportunity to anonymously express their opinion about the proposed statements.ResultsEighteen case series and case reports were retrieved from literature reporting on different surgical approaches and timing of thoracolumbar kyphosis surgery in MPS I. During the face-to-face meeting 16 statements were discussed and revised. Consensus was reached on all statements.ConclusionThis international consensus procedure resulted in the first clinical practice guideline for the management of thoracolumbar kyphosis in MPS I patients, focusing on the goals and timing of surgery, as well as the optimal surgical approach, the utility of bracing and required additional assessments (e.g. radiographs). Most importantly, it was concluded that the decision for surgery depends not only on the kyphotic angle, but also on additional factors such as the progression of the deformity and its flexibility, the presence of symptoms, growth potential and comorbidities. The eventual goal of treatment is the maintenance or improvement of quality of life. Further international collaborative research related to long-term outcome of kyphosis surgery in MPS I is essential as prognostic information is lacking.
机译:摘要背景在所有I型黏多糖贮积症(MPS I)患者中,骨骼疾病(多发性骨质疏松症)是一种与衰弱有关的重要并发症,可能会严重影响日常生活。不幸的是,用造血细胞移植(HCT)或酶替代疗法(ERT)不能缓解这种情况。尽管早期后凸畸形是重症肌无力的关键特征之一,但对于最佳治疗尚无国际共识。因此,组织了一项国际共识程序,旨在制定MPS I患者胸腰椎后凸畸形治疗的首个临床实践指南。方法进行了文献综述,以鉴定MPS I患者后凸畸形和相关手术的所有可用信息。随后,使用改进的Delphi程序来开发共识声明。专家小组成员包括10名脊柱整形外科医生,6名儿科医生和3名物理治疗师,他们都具有MPS I的经验。该程序包括2轮书面回合,面对面的会议和最后的书面回合。前两轮包含案例历史,一般性问题和陈述草案。在面对面会议期间,达成了共识声明。在最后一轮中,小组有机会匿名表达对建议陈述的意见。结果从文献中检索了18个病例系列和病例报告,这些文献报道了MPS I胸腰椎后凸畸形手术的不同手术方法和时机。面对面的会议上讨论和修订了16项声明。所有声明均已达成共识。结论这项国际共识程序导致了MPS I患者胸腰椎后凸畸形治疗的首个临床实践指南,重点关注手术的目标和时机,以及最佳手术方法,支架的实用性并需要额外的评估(例如射线照相)。最重要的是,得出的结论是,手术决定不仅取决于后凸角,还取决于其他因素,例如畸形的进展及其柔韧性,症状的存在,生长潜力和合并症。治疗的最终目标是维持或改善生活质量。由于缺乏预后信息,因此与MPS I的后凸畸形手术的长期结果相关的进一步国际合作研究至关重要。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号